SCHEMBL3066938

SCHEMBL3066938

CC(C)(C)NCC(O)CON

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10550374 0.98
SCHEMBL11381058 0.84 KMT2A (0.56)
SCHEMBL8962578 0.82 CYP2D6 (0.53)
SCHEMBL9645566 0.80 HTT (0.59)
SCHEMBL7348336 0.80 CYP2D6 (0.51)
SCHEMBL124180 0.80 CYP2D6 (0.51)
SCHEMBL7063746 0.80 CYP2D6 (0.48)
SCHEMBL14492443 0.76 CYP2D6 (0.43)
SCHEMBL8056773 0.76 CYP2D6 (0.43)
Hydrochloric Acid SCHEMBL9701373 0.74 CA12 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267711-A1 METHOD OF ENHANCING CELLULAR PRODUCTION OF MOLECULAR CHAPERONE, HYDROXYLAMINE DERIVATIVES USEFUL FOR ENHANCING THE CHAPERONE PRODUCTION AND THE PREPARATION THEREOF CYTRX CORPORATION (US) 2010-10-21 US disclosed
US-7148239-B2 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof CYTRX CORPORATION (US) 2006-12-12 US disclosed
US-20040019103-A1 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof BIOREX RESEARCH & DEVELOPMENT CO. 2004-01-29 US disclosed
US-6653326-B1 For example, N-(2-hydroxy-3-(1-piperidinyl)propoxy)-3-pyridinecarboximidoyl chloride maleate; inducing gene expression of an eukaryotic cell under physiological stress; antiallergens; autoimmune diseases; cardiovascular disorders BIOREX RESEARCH & DEVELOPMENT CO. (HU) 2003-11-25 US disclosed
EP-0801649-B1 HYDROXYLAMINE DERIVATIVES USEFUL FOR ENHANCING THE MOLECULAR CHAPERON PRODUCTION AND THE PREPARATION THEREOF BIOREX KUTATO FEJLESZTOE KFT (HU) 2002-08-07 EP disclosed
EP-0832079-B1 ANTI-ISCHAEMIC HYDROXYLAMINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS BIOREX KUTATO FEJLESZTOE KFT (HU) 2002-03-27 EP disclosed
US-20010051630-A1 Use of hydroxylamine derivatives, and method and preparations for increasing the tolerance of field crops against weather stresses JEDNAKOVITS ANDREA (HU) 2001-12-13 US disclosed
US-6002002-A Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions BIOREX RESEARCH & DEVELOPMENT CO. (HU) 1999-12-14 US disclosed
EP-0832079-A1 ANTI-ISCHAEMIC HYDROXYLAMINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS BIOREX KUTATO ES FEJLESZTÖ RT. (HU) 1998-04-01 EP disclosed
WO-1997000251-A1 ANTI-ISCHAEMIC HYDROXYLAMINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS BIOREX KUTATO ES FEJLESZTO RT. (HU) 1997-01-03 WO disclosed
US-4897412-A Imidazolines useful in lowering intraocular pressure LABORATORIES ALCON S.A. (FR) 1990-01-30 US disclosed
US-4801617-A Iminoimidazolidines useful in lowering intraocular pressure LABORATOIRES ALCON, S.A., 68240 KAYERSBERG, FRANCE, A CORP. OF FRANCE 1989-01-31 US disclosed
WO-1988007995-A2 COMPOUNDS POSSESSING BETA-ANTAGONISTIC AND ALPHA-ANTAGONISTIC PROERTIES, SUITABLE FOR LOWERING THE INTRAORBITAL PRESSURE, PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS, UTILIZATION THEREOF LABORATOIRES ALCON S.A. (FR) 1988-10-20 WO disclosed
US-4235899-A ANTIPROTOZOA AGENTS ESPECIALLY AGAINST TRICHOMONAS HOECHST AKTIENGESELLSCHAFT (DE) 1980-11-25 US disclosed